Filing Details
Minerva Neurosciences, Inc. (NASDAQ:NERV) filed a Form 8-K with the Securities and Exchange Commission on November 16, 2026, disclosing a material event.
Minerva Neurosciences, Inc. (NASDAQ:NERV) filed a Form 8-K with the Securities and Exchange Commission on November 16, 2026, disclosing a material event.

At publication ·
Minerva Neurosciences, Inc. (NASDAQ:NERV) · 8k filed
At a glance
Minerva Neurosciences, Inc. (NASDAQ:NERV) filed a Form 8-K with the Securities and Exchange Commission on November 16, 2026, disclosing a material event.
Minerva Neurosciences, Inc.'s stock currently trades at $2.30 with a market capitalization of $29.0M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Minerva Neurosciences, Inc.'s stock.
All SEC filings for Minerva Neurosciences, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View NERV Stock Page
Browse all filings on our NERV SEC filings page.
Public companies like Minerva Neurosciences, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
Current market data
NASDAQ · NERV
$2.20
Down: -$0.10 · -4.35%
Live quote updated
Keep reading
earnings ·
earnings ·
earnings ·
analyst ·